Xerostomia (dry mouth) is a common condition that can compromise oral health and overall well-being. It results from insufficient salivary gland secretion and often causes oral discomfort and difficulty with speech, swallowing and taste. This article summarises behavioural measures and commercial products that can enhance salivary flow, outlines principal aetiologies of xerostomia, and explains the role of saliva substitutes such as Aquoral in symptomatic care. Understanding these options helps patients and clinicians target relief and improve quality of life.

What Are the Primary Causes of Dry Mouth and Xerostomia?

Xerostomia may result from medications, systemic disease and lifestyle factors; identifying the underlying cause is essential for targeted management. Xerogenic medications, including antihistamines and some antidepressants, commonly reduce salivary secretion. Autoimmune disorders such as Sjögren’s and metabolic conditions like diabetes mellitus can impair salivary gland function. Behavioural contributors such as dehydration, tobacco use and excessive alcohol intake also reduce oral hydration. Recognizing these causes guides appropriate strategies to stimulate saliva production.

How Do Medications and Medical Conditions Affect Saliva Production?

Pharmacotherapy is a frequent cause of reduced salivary flow; agents such as antihistamines, diuretics and certain antidepressants are associated with xerostomia. Systemic conditions, particularly autoimmune diseases like Sjögren’s, can directly damage salivary gland tissue and produce chronic hyposalivation. Awareness of these effects supports consideration of alternative medications or adjunctive measures to manage symptoms.

Additional literature addresses comprehensive approaches to medication-induced dry mouth, including pharmacological adjustments, symptomatic therapies and preventive, multidisciplinary care.

Managing Medication-Induced Dry Mouth: Treatments & Saliva Stimulants

This review summarizes available treatment options, including substitution with agents that have lower xerogenic potential or dose reduction when feasible, in addition to preventive, multidisciplinary care that addresses contributing factors and oral symptoms. Several topical agents and saliva substitutes are discussed for symptomatic relief. Novel methods such as intraoral electrostimulation and topical application of anticholinesterase to the oral mucosa are also considered. The most commonly prescribed pharmacological treatments for dry mouth are pilocarpine and cevimeline.

Medication-induced xerostomia and hyposalivation in the elderly: culprits, complications, and management, 2018

Which Natural Methods Effectively Stimulate Saliva Production?

Non-pharmacological measures can increase salivary output and ease symptoms of xerostomia. These interventions mainly focus on hydration and dietary choices that preserve oral moisture.

How Does Hydration and Diet Influence Oral Mucosa Hydration?

Adequate systemic hydration is fundamental to oral mucosal moisture and salivary secretion. Regular oral fluid intake throughout the day helps preserve mucosal moisture. Including high-water-content foods such as cucumber, watermelon and oranges supports fluid balance. Chewing fibre-rich items like apples and carrots increases masticatory activity and thereby stimulates salivary flow.

What Oral Exercises and Lifestyle Changes Promote Saliva Secretion?

Targeted oral activities and lifestyle modification can raise salivary output. Chewing sugar-free gum or sucking sugar-free lozenges stimulates mechanoreceptors and activates the salivary glands. Good oral hygiene, including routine brushing and interdental cleaning, maintains a healthy environment and supports salivary function. Tobacco cessation and reducing caffeine and alcohol intake are recommended to lessen xerostomia.

How Do Saliva Production Aids and Products Like Aquoral Spray Treat Dry Mouth?

Saliva substitutes and topical aids are central to symptomatic management of dry mouth. Aquoral is a saliva substitute spray intended to stimulate and maintain oral hydration, providing relief for people with xerostomia. The formulation imitates aspects of natural saliva to alleviate oral discomfort and support mucosal health.

What Are the Clinical Benefits and Usage Guidelines of Aquoral Spray?

Aquoral supplies prolonged mucosal lubrication and symptomatic relief for patients with reduced salivary secretion. For effective use, apply Aquoral as a directed spray into the oral cavity following the recommended dosing instructions. Regular administration can improve oral hydration and patient comfort.

How Do Saliva Substitutes Compare to Pharmaceutical Treatments?

Saliva substitutes such as Aquoral provide immediate symptomatic lubrication by replacing deficient saliva, while systemic pharmaceutical agents typically aim to increase endogenous salivary secretion or treat underlying conditions. Substitutes are particularly useful for medication-induced or transient xerostomia when rapid relief is required. Understanding these different mechanisms helps select the most appropriate therapy.

What Are Condition-Specific Strategies for Managing Dry Mouth?

Management of xerostomia often requires condition-specific strategies. Patients with Sjögren’s or those undergoing cancer treatments present particular challenges in salivary function and benefit from tailored care plans.

How Is Dry Mouth Managed in Sjögren’s and Cancer Treatments?

In Sjögren’s, a comprehensive plan commonly includes saliva substitutes, regular dental monitoring and lifestyle measures to optimise hydration. Patients receiving head and neck radiotherapy may develop pronounced salivary hypofunction. In these situations, saliva substitutes, maintenance of systemic hydration and strict oral hygiene can reduce symptom severity.

What Are the Impacts of CPAP Therapy and Neurological Diseases on Saliva Production?

Continuous positive airway pressure (CPAP) therapy can cause nocturnal oral dryness due to airflow. Adding humidification is recommended to preserve mucosal moisture. Neurological disorders such as Parkinson’s disease may impair neural control of salivary glands and alter secretion. Recognising these mechanisms enables development of targeted strategies tailored to individual needs.

Additionally, certain neurological diseases can affect saliva production and require specific management approaches.